Avalo Therapeutics Shares Financial Results and Strategic Developments for 2024
March 20, 2025 - 10:26
Avalo Therapeutics has announced its financial results for 2024, highlighting significant updates regarding its ongoing clinical trials and organizational changes. The company is eagerly anticipating topline data from the Phase 2 LOTUS Trial of AVTX-009, which is being investigated for the treatment of hidradenitis suppurativa. This crucial data is expected to be released in 2026, marking an important milestone in Avalo's research and development efforts.
In a strategic move to bolster its leadership team, Avalo has appointed Jennifer Riley as the Chief Strategy Officer. Her expertise is expected to enhance the company's strategic direction as it navigates the complex landscape of biotechnology.
As of December 31, 2024, Avalo reported having approximately $135 million in cash reserves. This financial position is projected to provide sufficient runway into at least 2027, allowing the company to continue its focus on advancing innovative treatments for immune dysregulation.
MORE NEWS
August 21, 2026 - 03:11
Ballet Student Jessica Wang Makes Tiaras Her BusinessFor most ballet students, the focus is on perfecting a pirouette or landing a role in the spring showcase. For Jessica Wang, the real challenge came offstage: building a small business that makes...
August 20, 2026 - 13:00
Baldwin Park business trying to pivot after leak leaves them closedA sudden pipe leak has forced Lafayette & Rushford, a home decor store in Baldwin Park, to close its doors indefinitely. The damage from the water is significant, and the owners say they have no...
August 19, 2026 - 21:02
How Small Businesses Can Save 10% on the Supplies They Need to SucceedRunning a small business means watching every dollar, especially when it comes to routine purchases like office paper, cleaning products, or shipping boxes. These expenses add up quickly, but there...
August 19, 2026 - 04:32
Scott Seaman Selected to Crain’s Chicago Business 2026 Notable Leaders in Accounting, Consulting & LawHinshaw & Culbertson LLP has announced that Scott Seaman, a partner and co-chair of the firm`s global Insurance Services group, has been recognized by Crain`s Chicago Business as a 2026 Notable...